BOYDSense SAS is the subsidiary of Alpha MOS (EuroNext: ALNEO) which is developing a miniaturized breath analysis platform for monitoring chronic diseases, with a first application in diabetes. Today, BOYDSense announces the appointment of Ben Delhey as President of the company.
Ben Delhey has over 20 years of experience as a senior executive in the healthcare industry, with particular expertise in medical devices and applications. He has worked for leading pharmaceutical and Medtech companies in the field of diabetes, such as Bayer-Ascencia, Sanofi, Johnson & Johnson and LifeScan.
Ben Delhey is a specialist in the launch of new medical devices. During his career in sales and marketing, he has launched more than a dozen diabetes devices and apps that have been distributed in more than 25 countries around the world. He was the commercial lead for the implementation and execution of a new category of diabetes products whose drug dosing is based on algorithms.
“I am very proud of the position entrusted to me by the Supervisory Board of BOYDSense. We are entering a new era in terms of technologies applied to diabetes. The last few years have been very dynamic with the release of new innovations. The BOYDSense device will significantly improve the way diabetic patients will measure their blood glucose levels. This innovation will greatly facilitate the daily life of diabetic patients, allowing them to monitor their glucose levels in a simpler way”, comments Ben Delhey .
Anton Kittelberger, Chairman of the Supervisory Board, adds: “His experience in global medical device companies makes Ben the ideal leader for BOYDSense. He has launched numerous medical devices and has a strong network in the diabetes industry including from leading experts. Ben has the necessary skills to accelerate the development of the BOYDSense breath analysis platform as well as to commercialize it. After the endorsement of the Eurobiomed cluster and the financial support of the European Union , Ben’s arrival is another major milestone for BOYDSense.”
contacts
:
Ben Delhey – President of BOYDSense SAS –
www.boydsense.com
– +49 163 557 0055
Gildas de la Monneraye – Mascaret DC – www.mascaret.eu – +33 (
0)6 58 18 78 25
About BOYDSense
BOYDSense SAS is the subsidiary of Alpha MOS (EuroNext: ALNEO) which develops a miniaturized non-invasive breath analysis platform for the monitoring of chronic diseases based on volatile organic compounds (VOCs). The device, dubbed Lassie, is protected by 16 patents and is currently undergoing its second clinical trial.
About Alpha MOS
Alpha MOS (Euronext Paris, ISIN: FR0013421286 ALNEO) is an expert in sensory analysis. The company is a world leader in the creation of electronic noses, tongues and eyes for industrial use. Founded in 1993, Alpha MOS is an international company with subsidiaries in France, China and the United States.
This publication has the service “? Actusnews SECURITY MASTER”.
– SECURITY MASTER Key:
ypxyY51nZWudmW9yY8uZapdqmWljkmKbmJSbmJOcZp7IbmpglmuSm8bLZnBklW1o
– To check this key:
https://www.security-master-key.com.
Regulated information:
Inside information:
– Other press releases
Full and original press release in PDF format:
https://www.actusnews.com/news/73082-2022-02-03-cp-nomination-ben-delhey-fr.pdf
© Copyright Actusnews Wire
Receive the company’s next press releases free of charge by email by subscribing to www.actusnews.com